TY - JOUR
T1 - Computed Tomography-Guided Placement of Sacral Electrodes
AU - Rosen, Ada
AU - Elias, Sorin
AU - Herman, Hadas Ganer
AU - Condrea, Alexander
AU - Ginath, Shimon
N1 - Publisher Copyright:
© 2021 Israel Medical Association. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Background: The current approach to performing sacral neuromodulation consists of a two-stage procedure, the first of which includes insertion of the sacral electrode under fluoroscopic visualization of the S3 foramen. Alternatively, in certain situations computed tomography (CT)-guided insertion can be used. Objectives: To evaluate the use of CT in cases of reinsertion of the electrode due to infection, dislocation, or rupture. Methods: Medical records of patients who underwent neuromodulation device reinsertion between 2005 and 2016 for fecal incontinence were reviewed. Study outcomes included procedure course, successful placement, and long-term treatment success. Results: During the study period, we inserted a neuromodulation device in 67 patients. A CT-guided insertion of a sacral electrode was performed in 10 patients. In nine patients, the insertion and the final location of the electrode were successful. In one patient, the electrode migrated upward due to a malformation of the S3 foramen on both sides and had to be placed in S4. In a mean follow-up of 68.4 ± 30.0 months following the re-insertion, there was a significant reduction in the number of incontinence episodes per day (P < 0.001) and the number of pads used per day (P = 0.002). Conclusions: CT-guided insertion of a sacral electrode is a safe and promising option, especially in recurrent and or selected cases.
AB - Background: The current approach to performing sacral neuromodulation consists of a two-stage procedure, the first of which includes insertion of the sacral electrode under fluoroscopic visualization of the S3 foramen. Alternatively, in certain situations computed tomography (CT)-guided insertion can be used. Objectives: To evaluate the use of CT in cases of reinsertion of the electrode due to infection, dislocation, or rupture. Methods: Medical records of patients who underwent neuromodulation device reinsertion between 2005 and 2016 for fecal incontinence were reviewed. Study outcomes included procedure course, successful placement, and long-term treatment success. Results: During the study period, we inserted a neuromodulation device in 67 patients. A CT-guided insertion of a sacral electrode was performed in 10 patients. In nine patients, the insertion and the final location of the electrode were successful. In one patient, the electrode migrated upward due to a malformation of the S3 foramen on both sides and had to be placed in S4. In a mean follow-up of 68.4 ± 30.0 months following the re-insertion, there was a significant reduction in the number of incontinence episodes per day (P < 0.001) and the number of pads used per day (P = 0.002). Conclusions: CT-guided insertion of a sacral electrode is a safe and promising option, especially in recurrent and or selected cases.
KW - Computed tomography (CT)-guided
KW - Neuromodulation
KW - Sacral electrode
KW - reinsertion
UR - http://www.scopus.com/inward/record.url?scp=85123036545&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34954915
AN - SCOPUS:85123036545
SN - 1565-1088
VL - 23
SP - 773
EP - 776
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 12
ER -